Searched for
PHARMA FDI PROPOSALS
Government weighs relaxing FDI norms in brownfield pharma companiesAccording to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...- Government clears 10 FDI proposals worth Rs 1,675 croreBased on the recommendations of FIPB meeting of June 15, the govt has approved 10 proposals of FDI amounting to Rs 1,675.15 crore, a FinMin...
- Government approves FDI worth Rs 4,000 crore by four pharma firmsTorrent Pharmaceuticals' proposal for increasing FII investment limit to 35 per cent from 13.09 per cent was the biggest in terms of value ...
- FDI in pharma doubled during April to DecemberThe government had cleared a Rs 5,168 crore proposal of US-based pharma firm Mylan Inc's to acquire Indian generic drugs company Agila Spec...
- FIPB to decide on GlaxoSmithKline, other pharma FDI proposalsFIPB will take up tomorrow GlaxoSmithKline's Rs 6,400 crore FDI plan, the largest foreign investment proposal in the pharma sector this fis...
- FDI in pharma sector jumps 86.5% during April-Oct periodFDI in drugs and pharmaceuticals was at $580 million during April-October 2012, according to the data of the Department of Industrial Polic...
- Government not to reduce FDI cap in existing pharma companiesCurrently, 100 per cent FDI is permitted in brownfield pharma firms through clearance from the Foreign Investment Promotion Board (FIPB).
- Cabinet defers decision on FDI in pharma, housingThe decision on FDI in pharma and housing has been deferred, Information and Broadcasting Minister Manish Tewari said after the Cabinet mee...
- Government may review FDI policy in pharmaceutical, housing tomorrowThe Cabinet would also deliberate on the stand to be taken by India in the forthcoming WTO meet in Bali between December 3-6.
- Commerce Ministry seeks 49% FII, FDI cap in existing drug companiesThe Ministry of Commerce and Industry has proposed tighter overseas investment norms in existing drug companies by limiting all forms of fo...
- Cabinet may decide on FDI in pharma, housing tomorrowDIPP has proposed to reduce FDI cap from 100 per cent to 49 per cent in the "rare or critical pharma verticals".
- FDI in pharma sector doubled during April-AugustFaced with rush of multinationals to acquire Indian pharma firms, the Commerce and Industry Ministry is proposing to tighten the FDI policy...
- DIPP for stringent conditions in FDI in existing pharma companiesThe total investment as per the condition proposed would have to incurred within 3 years of the acquisition, they said.
- Planning Commission rejects DIPP proposal to limit FDI in pharmaThe Planning Commission has opposed a proposal by DIPP to limit foreign direct investment in companies making ‘critical drugs’ to 49%.
- Govt to soon finalise FDI policy on pharma sectorChidambaram today said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects.
- Foreign Investment Promotion Board gives go ahead to 7 pharma FDI proposalsDIPP, the nodal body for framing FDI policy, wants to review the policy to ensure there are enough safeguards to ensure domestic healthcare...
- FIPB clears seven pharma FDI proposal, defers threeThe FIPB discussed 30 Foreign Direct Investment (FDI) proposals, including 10 from pharma sector.
- Govt to finalise FDI policy in pharma before FIPB meetThe government is likely to finalise FDI policy with regard to existing drug companies ahead of the FIPB meeting on July 5.
- Government likely to clear FDI proposals worth Rs 3000 crore by companies including Pfizer, B Braun and Sutures IndiaNodal body for FDI policy DIPP to issue clarifications, paving the way for FIPB to take up pending proposals of Pfizer, B Braun & Sutures I...
- Ministers' panel to look into FDI in pharma sectorThe immediate trigger for the move was the acquisition of Ahmedabad-based Paras Pharmaceuticals by British consumer goods and healthcare fi...
Load More
